Corporate News     06-Nov-23
Zydus receives USFDA approval for ZITUVIMET™ (Sitagliptin and Metformin hydrochloride) tablets
Zydus Lifesciences announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for ZITUVIMET™ (Sitagliptin and Metformin hydrochloride) tablets, 50 mg/500 mg and 50 mg/1000 mg.

ZITUVIMET™ contains active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Previous News
  Zydus Life arm inks pact with Daewoong Pharma to market Leuprolide Acetate
 ( Hot Pursuit - 11-Dec-23   11:22 )
  Zydus Life gets tentative USFDA approval for Letermovir tablets
 ( Hot Pursuit - 23-Mar-24   14:21 )
  Zydus receives USFDA approval for Diclofenac Sodium and Misoprostol Delayed Release Tablets
 ( Corporate News - 13-Jun-23   15:11 )
  Zydus Life rises as Q2 PAT soars 53% YoY to Rs 801 cr
 ( Hot Pursuit - 07-Nov-23   15:23 )
  Zydus Life gets USFDA nod for depression drug
 ( Hot Pursuit - 24-Mar-23   11:08 )
  Zydus Lifesciences receives USFDA approval for Varenicline Tablets
 ( Corporate News - 13-Jun-23   14:42 )
  Zydus receives USFDA approval for Mirabegron Extended-Release Tablets
 ( Corporate News - 03-Oct-22   09:09 )
  Zydus receives affirmation in ratings for bank facilities
 ( Corporate News - 11-Jan-23   11:34 )
  Zydus Lifesciences launches cancer drug - IBYRA in India
 ( Corporate News - 13-Mar-24   16:31 )
  Zydus announces NDA acceptance of Desidustat in China by NMPA
 ( Corporate News - 23-Apr-24   16:06 )
  Zydus enters into licensing and supply agreement with Synthon BV for Palbociclib Tablets
 ( Corporate News - 19-Jan-24   09:15 )
Other Stories
  GRP schedules AGM
  01-Jul-24   20:01
  Mahindra & Mahindra domestic PV sales jump 23% in June
  01-Jul-24   20:01
  Vipul Organics constructs new factory in Ambernath, Maharashtra
  01-Jul-24   20:00
  Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
  01-Jul-24   19:41
  Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
  01-Jul-24   19:39
  Rama Phosphates AGM scheduled
  01-Jul-24   19:34
  Take Solutions to convene AGM
  01-Jul-24   19:34
  Fischer Medical Ventures partners with Singapore-based Nervotec
  01-Jul-24   19:29
  NIIT appoints Pankaj Jathar as Chief Executive Officer
  01-Jul-24   19:27
  Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
  01-Jul-24   19:26
Back Top